What is the usual nursing expectation after administering magnesium sulfate for preeclampsia?

Monitoring for signs of reduced urine output is a crucial nursing expectation after administering magnesium sulfate for preeclampsia because magnesium sulfate can affect renal function. This medication can lead to muscle relaxation, including that of the urinary tract, and potentially decrease urine output. It is essential for nurses to monitor fluid balance and renal status closely to detect any adverse effects and to ensure that the treatment remains safe and effective for the patient.

The other choices do not align with the critical care needed following the administration of magnesium sulfate. Increasing activity levels may not be advisable for a patient in a state of preeclampsia due to the risk of complications and the need for careful monitoring. Encouraging increased fluid intake can be inappropriate, especially if the patient is showing signs of reduced urine output or has restrictions on fluid intake. Discharging a patient immediately from the hospital after administering magnesium sulfate would negate the necessary monitoring and evaluation needed to assess the patient’s response to the medication and overall condition.